Funds holding SpyGlass Pharma Inc
ISIN US85220G1094 · United States
- Fund holders
- 19
- Of which ETFs
- 0 19 other funds
- Value held
- 39.8M $
- Share of capital
- 4.6 % of 33.4M shares on Jul 29, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 317,053 | 8.2M $ | 0.00 % | 0.95 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 299,416 | 7.8M $ | 0.36 % | 0.90 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 290,792 | 7.5M $ | 0.07 % | 0.87 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 229,809 | 6M $ | 0.05 % | 0.69 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 109,328 | 2.5M $ | 0.24 % | 0.33 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 108,374 | 2.8M $ | 0.00 % | 0.32 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 95,508 | 2.5M $ | 0.17 % | 0.29 % | as of Mar 31, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 44,477 | 1.2M $ | 0.10 % | 0.13 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 17,450 | 452.1K $ | 0.07 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 7,200 | 165.2K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 5,992 | 155.3K $ | 0.07 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 5,404 | 140K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 4,214 | 109.2K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 3,982 | 103.2K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 3,259 | 91.3K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 3,190 | 82.7K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 1,244 | 28.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 320 | 9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 101 | 2.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 0.36 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.24 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 0.17 % | as of Mar 31, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 0.10 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.07 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 0.05 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 0.01 % | as of Mar 31, 2026 ↗ |
Institutional managers
31 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8,021,117 | 207.8M $ | as of Mar 31, 2026 |
| NEA Management Company, LLC | 7,392,301 | 191.5M $ | as of Mar 31, 2026 |
| Sands Capital Alternatives, LLC | 2,500,012 | 64.8M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 2,109,953 | 54.7M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 704,440 | 18.3K $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 666,760 | 17.3M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 577,109 | 13.5M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 550,000 | 14.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 468,794 | 12.1M $ | as of Mar 31, 2026 |
| First Light Asset Management, LLC | 375,000 | 9.7M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 300,000 | 7.8M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 250,000 | 6.5M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 220,454 | 5.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 144,739 | 3.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 126,540 | 3.3M $ | as of Mar 31, 2026 |
| Monashee Investment Management LLC | 95,000 | 2.5M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 59,610 | 1.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 57,000 | 1.5M $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 47,580 | 1.2M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 44,477 | 1.2M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 29,348 | 760.4K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 28,020 | 726K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 20,862 | 540.5K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 19,283 | 499.6K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 17,250 | 446.9K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding SpyGlass Pharma Inc". https://titelia.com/en/stocks/spyglass-pharma-inc-US85220G1094